News | November 14, 2014

Prestige Medical Imaging Partners With VuComp Inc. For New Technologies to Detect Breast Cancer

M-Vu Breast Density is designed to advance the science of breast density measurement by identifying dense tissue in the breast that could be masking cancer.

Nov. 14, 2014 – Prestige Medical Imaging (PMI) will partner with VuCOMP Inc., a developer of advanced computer vision systems for the detection of breast cancer. VuCOMP has developed and commercialized two breast-imaging products, M-Vu CAD and M-Vu Breast Density.  M-Vu CAD analyzes mammograms to mark areas consistent with breast cancer using sophisticated mathematical algorithms.

M-Vu Breast Density is designed to advance the science of breast density measurement by identifying dense tissue in the breast that could be masking cancer. In addition, VuCOMP has a works-in-progress CAD solution for 3-D breast tomosynthesis in development. 

CEO of Prestige Medical Imaging Bill Haussmann, Chief Executive Officer commented, “Our customers are requiring more advanced technology in performing diagnostic exams particularly with reading dense breast tissue mammography exams. The addition of VuCOMP’s innovative technology to Prestige Medical Imaging’s portfolio addresses these needs by offering an automated, consistent and efficient assessment tool. This offering expands our portfolio and extends our market reach into Women’s Healthcare.”

For more information: www.prestigemedicalimaging.com, www.vucomp.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
ContextVision Introduces AI-Powered Image Enhancement for Digital Radiography
Technology | Artificial Intelligence | November 09, 2018
With the integration of deep learning technology, ContextVision takes digital radiography to new levels with its latest...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Siemens Healthineers Announces FDA Clearance of Cios Spin Mobile 3D C-Arm
Technology | Mobile C-Arms | November 06, 2018
Siemens Healthineers announced the U.S. Food and Drug Administration (FDA) clearance of the Cios Spin, a new mobile C-...
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Volpara Enterprise Cloud Reaches 1 Million Mammograms Stored
News | Mammography | October 31, 2018
Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic...